CRENESSITY Trademark

Trademark Overview


On Wednesday, January 29, 2025, a trademark application was filed for CRENESSITY with the United States Patent and Trademark Office. The USPTO has given the CRENESSITY trademark a serial number of 99975033. The federal status of this trademark filing is PRIORITY ACTION MAILED as of Monday, June 9, 2025. This trademark is owned by Neurocrine Biosciences, Inc.. The CRENESSITY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
crenessity

General Information


Serial Number99975033
Word MarkCRENESSITY
Filing DateWednesday, January 29, 2025
Status658 - PRIORITY ACTION MAILED
Status DateMonday, June 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear in dark purple, purple, dark orange, orange from left to right and are positioned above the word CRENESSITY.
Goods and Servicespharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
Indication of Colors claimedThe color(s) dark purple, purple, dark orange, and orange is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 30, 2025
Primary Code005
First Use Anywhere DateSaturday, December 21, 2024
First Use In Commerce DateSaturday, December 21, 2024

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Wednesday, January 29, 2025APPLICATION FILING RECEIPT MAILED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 22, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 4, 2025ASSIGNED TO EXAMINER
Monday, June 9, 2025PRIORITY ACTION WRITTEN
Wednesday, January 29, 2025NEW APPLICATION ENTERED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 22, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 9, 2025NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 9, 2025PRIORITY ACTION E-MAILED
Thursday, July 10, 2025USE AMENDMENT FILED
Thursday, July 10, 2025AMENDMENT TO USE PROCESSING COMPLETE
Thursday, July 10, 2025DIVISIONAL REQUEST RECEIVED
Thursday, July 10, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, July 10, 2025TEAS AMENDMENT OF USE RECEIVED
Monday, July 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 23, 2025DIVISIONAL PROCESSING COMPLETE
Friday, July 18, 2025ASSIGNED TO LIE